• Accueil >
  • Publications >
  • Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)

Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)

1 oct. 2015Annals of Oncology

DOI : 10.1093/annonc/mdv300

Auteurs

E. Bompas, A. Le Cesne, E. Tresch-Bruneel, L. Lebellec, V. Laurence, O. Collard, E. Saada-Bouzid, N. Isambert, J.Y. Blay, E.Y. Amela, S. Salas, C. Chevreau, F. Bertucci, A. Italiano, S. Clisant, N. Penel